Guam vs Poland: The number of people with susceptibility test result for rifampicin
Guam
92.11
in 2021
Poland
91.55
in 2021
Guam rank
62nd
Poland rank
65th
The number of people with susceptibility test result for rifampicin over time
- Guam
- Poland
How they compare
Guam currently reports 92.11 against 91.55 in Poland, a difference of 0.56.
Across all 5 years both countries report, Guam has been ahead every year.
Guam ranks 62nd and Poland ranks 65th of 146 countries.
Guam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guam | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.77 | 89.97 | 8.8 | Guam |
| 2020s | 94.77 | 90.9 | 3.87 | Guam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guam or Poland?
- Guam, at 92.11 against 91.55 in Poland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guam and Poland?
- 0.56, with Guam ahead.
- How many years of comparable data are there for Guam and Poland?
- 5 years are reported by both, from 2017 to 2021.
- How do Guam and Poland rank globally for the number of people with susceptibility test result for rifampicin?
- Guam ranks 62nd and Poland ranks 65th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.